A phase II trial of modified weekly irinotecan and cisplatin for chemotherapy-naïve patients with metastatic or recurrent squamous cell carcinoma of the esophagus.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples